Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1373831.RAFm06OlVA6EmqJU5n7Yn9CsdB0iww1lG8GnqjsK0PNNM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1373831.RAFm06OlVA6EmqJU5n7Yn9CsdB0iww1lG8GnqjsK0PNNM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1373831.RAFm06OlVA6EmqJU5n7Yn9CsdB0iww1lG8GnqjsK0PNNM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1373831.RAFm06OlVA6EmqJU5n7Yn9CsdB0iww1lG8GnqjsK0PNNM130_provenance.
- NP1373831.RAFm06OlVA6EmqJU5n7Yn9CsdB0iww1lG8GnqjsK0PNNM130_assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1373831.RAFm06OlVA6EmqJU5n7Yn9CsdB0iww1lG8GnqjsK0PNNM130_provenance.
- NP1373831.RAFm06OlVA6EmqJU5n7Yn9CsdB0iww1lG8GnqjsK0PNNM130_assertion evidence source_evidence_literature NP1373831.RAFm06OlVA6EmqJU5n7Yn9CsdB0iww1lG8GnqjsK0PNNM130_provenance.
- NP1373831.RAFm06OlVA6EmqJU5n7Yn9CsdB0iww1lG8GnqjsK0PNNM130_assertion SIO_000772 9168435 NP1373831.RAFm06OlVA6EmqJU5n7Yn9CsdB0iww1lG8GnqjsK0PNNM130_provenance.
- NP1373831.RAFm06OlVA6EmqJU5n7Yn9CsdB0iww1lG8GnqjsK0PNNM130_assertion wasDerivedFrom befree-2016 NP1373831.RAFm06OlVA6EmqJU5n7Yn9CsdB0iww1lG8GnqjsK0PNNM130_provenance.
- NP1373831.RAFm06OlVA6EmqJU5n7Yn9CsdB0iww1lG8GnqjsK0PNNM130_assertion wasGeneratedBy ECO_0000203 NP1373831.RAFm06OlVA6EmqJU5n7Yn9CsdB0iww1lG8GnqjsK0PNNM130_provenance.
- befree-2016 importedOn "2016-02-19" NP1373831.RAFm06OlVA6EmqJU5n7Yn9CsdB0iww1lG8GnqjsK0PNNM130_provenance.